Assessing eligibility for lung cancer screening using parsim

Thomas Callender and colleagues present a development and validation study using parsimonious ensemble machine learning models to assess eligibility for lung cancer screening.

Related Keywords

United Kingdom , United States , Astra Zeneca , Sujin Kang , Arjun Nair , Stephen Duffy , Mortimer Health , National Lung Screening Trial , National Health Service , National Cancer Institute , Wellcome , Bristol Myers Squibb , Pfizer , National Science Foundation , Guardant Health , Us National Institutes Of Health , Us National Lung Screening , Research Council , Boehringer Ingelheim , Amgen , Us National Lung Screening Trial , Cancer Research United Kingdom , Us Preventive Services Taskforce , United Kingdom Biobank , Lung Screening , Lung Screening Trial , Cancer Screening Trial , Creative Commons Attribution License , Wellcome Trust , Medical Research Council , Merck Sharp , Lung Cancer Risk Assessment Tool , Lung Cancer Death Risk Assessment Tool , Liverpool Lung Project , Ovarian Cancer Screening Trial , Services Taskforce , United Kingdom Biobank Resource , Lung And Intrathoracic Tumors , Cancer Risk Factors , Cancer Screening , Machine Learning , Smoking Habits , Colorectal Cancer , Forecasting , Prostate Cancer ,